| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/07853890.2013.783994 |
| P698 | PubMed publication ID | 23651009 |
| P2093 | author name string | Christopher L-H Huang | |
| Claire A Martin | |||
| Gareth D K Matthews | |||
| P2860 | cites work | MiRP1 forms IKr potassium channels with HERG and is associated with cardiac arrhythmia | Q22009462 |
| Cardiac conduction defects associate with mutations in SCN5A | Q22010507 | ||
| Loss-of-function mutation of the SCN3B-encoded sodium channel {beta}3 subunit associated with a case of idiopathic ventricular fibrillation | Q24293547 | ||
| A cardiac arrhythmia syndrome caused by loss of ankyrin-B function | Q24295030 | ||
| Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak | Q24296910 | ||
| A novel form of short QT syndrome (SQT3) is caused by a mutation in the KCNJ2 gene | Q24297875 | ||
| Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) decreases cardiac Na+ current and causes inherited arrhythmias | Q24298971 | ||
| Familial sinus bradycardia associated with a mutation in the cardiac pacemaker channel | Q24300840 | ||
| Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans | Q24608179 | ||
| Epidemiology of sudden cardiac death: clinical and research implications | Q24650947 | ||
| Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org) | Q24654954 | ||
| Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome | Q24655604 | ||
| Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death | Q24675134 | ||
| Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes | Q27030767 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A) | Q28206505 | ||
| The genetic basis of Brugada syndrome: a mutation update | Q28252115 | ||
| Enhanced store overload-induced Ca2+ release and channel sensitivity to luminal Ca2+ activation are common defects of RyR2 mutations linked to ventricular tachycardia and sudden death | Q28278262 | ||
| Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia | Q28279395 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| The mechanism of catecholaminergic polymorphic ventricular tachycardia may be triggered activity due to delayed afterdepolarization | Q28306389 | ||
| Impaired impulse propagation in Scn5a-knockout mice: combined contribution of excitability, connexin expression, and tissue architecture in relation to aging | Q28593454 | ||
| Modelling the long QT syndrome with induced pluripotent stem cells | Q29620092 | ||
| Role of programmed ventricular stimulation in patients with Brugada syndrome: a meta-analysis of worldwide published data | Q31111759 | ||
| "Brugada" syndrome: clinical data and suggested pathophysiological mechanism | Q31913453 | ||
| Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. | Q33145274 | ||
| Autosomal recessive catecholamine- or exercise-induced polymorphic ventricular tachycardia: clinical features and assignment of the disease gene to chromosome 1p13-21. | Q33146452 | ||
| Yield of genetic screening in inherited cardiac channelopathies: how to prioritize access to genetic testing. | Q43266239 | ||
| Paradoxic abbreviation of repolarization in epicardium of the right ventricular outflow tract during augmentation of Brugada-type ST segment elevation | Q43858714 | ||
| Ventricular arrhythmia induced by sodium channel blocker in patients with Brugada syndrome | Q44648714 | ||
| Cellular and ionic basis for the sex-related difference in the manifestation of the Brugada syndrome and progressive conduction disease phenotypes | Q44723715 | ||
| Delay in right ventricular activation contributes to Brugada syndrome | Q44781964 | ||
| Gender difference and drug challenge in Brugada syndrome | Q44803535 | ||
| Are women with severely symptomatic brugada syndrome different from men? | Q46056314 | ||
| Action potential alternans in the right ventricular outflow tract in a patient with asymptomatic Brugada syndrome | Q46201813 | ||
| High-density substrate mapping in Brugada syndrome: combined role of conduction and repolarization heterogeneities in arrhythmogenesis. | Q46269742 | ||
| Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population | Q46301151 | ||
| Mutation in the KCNQ1 gene leading to the short QT-interval syndrome | Q47438291 | ||
| Compound mutations: a common cause of severe long-QT syndrome | Q47857406 | ||
| Postmortem long QT syndrome genetic testing for sudden unexplained death in the young | Q48480320 | ||
| Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome. | Q50632243 | ||
| Population-based analysis of sudden cardiac death with and without left ventricular systolic dysfunction: two-year findings from the Oregon Sudden Unexpected Death Study. | Q50778872 | ||
| Clinical course and risk stratification of patients affected with the Jervell and Lange-Nielsen syndrome. | Q51145417 | ||
| QTc behavior during exercise and genetic testing for the long-QT syndrome. | Q51498727 | ||
| Sudden death in the general population in Okinawa: incidence and causes of death. | Q53732503 | ||
| A complex double deletion in LMNA underlies progressive cardiac conduction disease, atrial arrhythmias, and sudden death. | Q54383005 | ||
| Survivors of Out-of-Hospital Cardiac Arrest With Apparently Normal Heart: Need for Definition and Standardized Clinical Evaluation | Q55970441 | ||
| The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: a population-based study of four decades | Q33146752 | ||
| Natural history of Brugada syndrome: insights for risk stratification and management | Q33147491 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Body surface area of ST elevation and the presence of late potentials correlate to the inducibility of ventricular tachyarrhythmias in Brugada syndrome | Q33148073 | ||
| Proposed diagnostic criteria for the Brugada syndrome: consensus report | Q33148286 | ||
| Risk stratification in the long-QT syndrome. | Q33148941 | ||
| Implantable cardioverter defibrillator in high-risk long QT syndrome patients | Q33148945 | ||
| Natural history of Brugada syndrome: the prognostic value of programmed electrical stimulation of the heart | Q33148999 | ||
| Short QT Syndrome: a familial cause of sudden death | Q33149259 | ||
| Efficacy of quinidine in high-risk patients with Brugada syndrome | Q33151791 | ||
| Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases | Q33152066 | ||
| Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome | Q33152228 | ||
| Arrhythmogenic right ventricular dysplasia: a United States experience | Q33153393 | ||
| Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis | Q33154041 | ||
| Mouse models of long QT syndrome | Q33154363 | ||
| Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study | Q33154495 | ||
| Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia | Q33155477 | ||
| Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome | Q33156201 | ||
| Repolarization heterogeneity in the right ventricular outflow tract: correlation with ventricular arrhythmias in Brugada patients and in an in vitro canine Brugada model | Q33156240 | ||
| Sudden cardiac arrest associated with early repolarization | Q33156255 | ||
| Long-term prognosis of probands with Brugada-pattern ST-elevation in leads V1-V3. | Q33157954 | ||
| Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry | Q33158291 | ||
| Idiopathic ventricular fibrillation | Q33160592 | ||
| Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry. | Q33160801 | ||
| Brugada syndrome 2012. | Q33161523 | ||
| Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients | Q33173888 | ||
| Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome | Q33174622 | ||
| Early repolarization | Q33539317 | ||
| A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype | Q33572315 | ||
| An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing | Q33655317 | ||
| Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST-segment elevation | Q33876613 | ||
| The syndrome of right bundle branch block ST segment elevation in V1 to V3 and sudden death--the Brugada syndrome | Q33935865 | ||
| Ventricular fibrillation with prominent early repolarization associated with a rare variant of KCNJ8/KATP channel | Q34015485 | ||
| Early repolarization: electrocardiographic phenotypes associated with favorable long-term outcome | Q34027142 | ||
| Genetics of sudden cardiac death | Q34203505 | ||
| Sudden death associated with short-QT syndrome linked to mutations in HERG. | Q34283788 | ||
| Short QT syndrome: pharmacological treatment | Q34314532 | ||
| Cellular basis for the electrocardiographic J wave | Q34370136 | ||
| Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. | Q34385271 | ||
| Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. | Q34395488 | ||
| Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry | Q34422572 | ||
| Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. | Q34444862 | ||
| Out-of-hospital cardiac arrest in the 1990's: a population-based study in the Maastricht area on incidence, characteristics and survival | Q34445532 | ||
| Brugada syndrome: from cell to bedside | Q34667046 | ||
| Long QT syndrome, Brugada syndrome, and conduction system disease are linked to a single sodium channel mutation | Q34785746 | ||
| Mapping of reentrant spontaneous polymorphic ventricular tachycardia in a Scn5a+/- mouse model | Q34979810 | ||
| Estradiol promotes sudden cardiac death in transgenic long QT type 2 rabbits while progesterone is protective | Q35427930 | ||
| Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia | Q36037969 | ||
| Reduced Na(+) and higher K(+) channel expression and function contribute to right ventricular origin of arrhythmias in Scn5a+/- mice | Q36079245 | ||
| Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes | Q36140857 | ||
| The congenital long QT syndromes from genotype to phenotype: clinical implications | Q36335249 | ||
| Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing. | Q36399631 | ||
| The role of molecular autopsy in unexplained sudden cardiac death | Q36443125 | ||
| From pulsus to pulseless: the saga of cardiac alternans | Q36489923 | ||
| In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells | Q37005193 | ||
| Haplotype-sharing analysis implicates chromosome 7q36 harboring DPP6 in familial idiopathic ventricular fibrillation | Q37156064 | ||
| Prevalence of the congenital long-QT syndrome. | Q37442080 | ||
| Early repolarization syndrome – a new electrical disorder associated with sudden cardiac death –. | Q37788474 | ||
| Cardiac ion channel mutations in the sudden infant death syndrome | Q37826837 | ||
| Genetics of ion-channel disorders. | Q37997324 | ||
| Brugada electrocardiographic pattern induced by fever | Q37997443 | ||
| Ryanodine receptor physiology and its role in disease | Q37997675 | ||
| Electrocardiographic characteristics and SCN5A mutations in idiopathic ventricular fibrillation associated with early repolarization | Q39452561 | ||
| Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. | Q39722604 | ||
| Spatial and temporal heterogeneities are localized to the right ventricular outflow tract in a heterozygotic Scn5a mouse model | Q39814350 | ||
| Right ventricular fibrosis and conduction delay in a patient with clinical signs of Brugada syndrome: a combined electrophysiological, genetic, histopathologic, and computational study. | Q40355175 | ||
| Early afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current | Q41256047 | ||
| Structure of a complex between a voltage-gated calcium channel beta-subunit and an alpha-subunit domain. | Q41858723 | ||
| Distribution, splicing and glucocorticoid-induced expression of cardiac alpha 1C and alpha 1D voltage-gated Ca2+ channel mRNAs | Q42448384 | ||
| KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome | Q42665516 | ||
| Regional variations in action potential alternans in isolated murine Scn5a (+/-) hearts during dynamic pacing | Q43102967 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 364-374 | |
| P577 | publication date | 2013-05-08 | |
| P1433 | published in | Annals of Medicine | Q4767853 |
| P1476 | title | The role of ion channelopathies in sudden cardiac death: implications for clinical practice | |
| P478 | volume | 45 |
Search more.